---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-039264"
form_type: "8-K"
ticker: "CDXS"
cik: "0001200375"
company_name: "CODEXIS, INC."
filed_at: "2025-02-27T23:59:59+00:00"
generated_at: "2026-05-26T01:03:29.296752+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Codexis FY2024 revenue $59.3M, net loss $65.3M; guides 2025 revenue $64M-$68M

## Summary
- FY2024 total revenue $59.3M (-4% YoY ex-PAXLOVID); net loss $65.3M ($0.89/share) vs $76.2M ($1.12) in FY2023.
- Q4 total revenue $21.5M (+17% YoY ex-PAXLOVID); net loss $10.4M ($0.13/share) vs $7.2M ($0.10) in Q4 2023.
- Guides FY2025 total revenue $64M-$68M (double-digit growth); expects path to cash flow positivity by end of 2026.
- Cash, cash equivalents and short-term investments $73.5M at Dec 31, 2024; raised $31M via ATM in Sep 2024.
- Appointed Arthur Levin to Strategic Advisory Board; expects first ECO Synthesis contract in H1 2025 and GMP scale-up partner by end of 2025.

## SEC filing metadata
- accession: 0001193125-25-039264
- form_type: 8-K
- ticker: CDXS
- cik: 0001200375
- company_name: CODEXIS, INC.
- filed_at: 2025-02-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1200375/000119312525039264/0001193125-25-039264-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1200375/000119312525039264/d832121d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-039264
- JSON: https://secwatch.observer/filing/0001193125-25-039264.json
- Plain text: https://secwatch.observer/filing/0001193125-25-039264.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.